thiopental 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
hypnotics, barbituric acid derivatives 2633 76-75-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • pentothal
  • thiopental sodium
  • thiopental
  • thiomebumal
  • thionembutal
  • pentothiobarbital
A barbiturate that is administered intravenously for the induction of general anesthesia or for the production of complete anesthesia of short duration.
  • Molecular weight: 242.34
  • Formula: C11H18N2O2S
  • CLOGP: 2.98
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 2
  • TPSA: 58.20
  • ALOGS: -3.78
  • ROTB: 4
  • Status: OFM
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 1 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 50 mg/mL Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 0.50 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 20.63 µM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
Vd (Volume of distribution) 1.20 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 8.20 mL/min/kg Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma) 0.14 % Lombardo F, Berellini G, Obach RS
t_half (Half-life) 2 hours Lombardo F, Berellini G, Obach RS

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
kinase-safety-class ACVR2A,ACVR2B,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,ERBB2,GRK2,GSK3B,ITK,JAK2,MAP3K21,MAP3K7,MAPK10,MAPK7,NTRK2,PDK1,PDK2,PIK3CB,PIK3CD,PIM2,PRKDC,SIK2,STK33,SYK,TEK,TTK 34
kinase-selectivity-class AXL,BRAF,CAMK2D,CDK9,GRK2,MAPK7,PDK1,STK33,TEK 9
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

DateAgencyCompanyOrphan
None FDA ABBOTT

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Status epilepticus 192.13 63.79 54 2720 18820 90606853
Diabetes insipidus 165.07 63.79 34 2740 3178 90622495
Renal ischaemia 145.83 63.79 24 2750 642 90625031
PCO2 increased 129.56 63.79 24 2750 1289 90624384
Breast cancer recurrent 120.63 63.79 29 2745 5474 90620199
Blood pH decreased 113.59 63.79 24 2750 2534 90623139
PO2 increased 112.03 63.79 20 2754 872 90624801
Blood bicarbonate decreased 108.85 63.79 24 2750 3095 90622578
Foetal death 106.22 63.79 35 2739 20688 90604985
Left ventricular dysfunction 105.16 63.79 32 2742 14637 90611036
Oxygen saturation abnormal 101.24 63.79 24 2750 4264 90621409
Drug ineffective 100.29 63.79 162 2612 1384136 89241537
Exposure during pregnancy 87.27 63.79 66 2708 238344 90387329
Hypotension 83.09 63.79 73 2701 325324 90300349
Cardiac arrest 82.67 63.79 47 2727 104888 90520785
Seizure 80.82 63.79 53 2721 152576 90473097
Maternal exposure during pregnancy 74.83 63.79 72 2702 359991 90265682
Blood magnesium decreased 74.39 63.79 25 2749 15668 90610005
Multiple-drug resistance 73.40 63.79 21 2753 7755 90617918
Electroencephalogram abnormal 66.64 63.79 17 2757 4079 90621594
Intensive care unit acquired weakness 65.59 63.79 13 2761 998 90624675

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Drug ineffective 163.93 46.72 175 1923 630022 41989215
Status epilepticus 151.87 46.72 48 2050 15530 42603707
Intensive care unit acquired weakness 124.84 46.72 25 2073 1253 42617984
Multiple-drug resistance 116.68 46.72 33 2065 7289 42611948
Off label use 84.05 46.72 127 1971 638208 41981029
Diabetes insipidus 60.31 46.72 17 2081 3696 42615541
Muscle contracture 54.91 46.72 13 2085 1422 42617815
Haematuria traumatic 53.82 46.72 10 2088 335 42618902
Hepatitis fulminant 51.23 46.72 16 2082 4943 42614294
Drug ineffective for unapproved indication 47.29 46.72 29 2069 46134 42573103

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Status epilepticus 290.67 43.84 90 4612 31481 110553116
Drug ineffective 239.14 43.84 305 4397 1520235 109064362
Diabetes insipidus 215.12 43.84 51 4651 6519 110578078
Intensive care unit acquired weakness 193.83 43.84 39 4663 2320 110582277
Multiple-drug resistance 152.95 43.84 45 4657 13190 110571407
PCO2 increased 111.85 43.84 24 4678 1953 110582644
Renal ischaemia 107.99 43.84 24 4678 2299 110582298
Foetal death 103.63 43.84 35 4667 16010 110568587
PO2 increased 94.30 43.84 20 4682 1539 110583058
Blood pH decreased 91.34 43.84 24 4678 4645 110579952
Oxygen saturation abnormal 86.97 43.84 24 4678 5587 110579010
Blood bicarbonate decreased 86.19 43.84 24 4678 5773 110578824
Exposure during pregnancy 81.82 43.84 63 4639 167361 110417236
Left ventricular dysfunction 80.04 43.84 32 4670 23461 110561136
Off label use 79.57 43.84 187 4515 1499998 109084599
Maternal exposure during pregnancy 71.80 43.84 70 4632 254813 110329784
Multiple organ dysfunction syndrome 69.58 43.84 55 4647 151655 110432942
Generalised tonic-clonic seizure 67.84 43.84 37 4665 54643 110529954
Electroencephalogram abnormal 66.97 43.84 20 4682 6153 110578444
Drug ineffective for unapproved indication 66.81 43.84 46 4656 102792 110481805
Cardiac arrest 62.94 43.84 58 4644 196695 110387902
Malabsorption 61.91 43.84 19 4683 6406 110578191
Haematuria traumatic 60.93 43.84 11 4691 364 110584233
Blood magnesium decreased 60.44 43.84 25 4677 19971 110564626
Propofol infusion syndrome 58.85 43.84 15 4687 2574 110582023
Hypotension 57.04 43.84 89 4613 523760 110060837
Seizure 55.35 43.84 57 4645 221128 110363469
Partial seizures 55.01 43.84 20 4682 11329 110573268
Maternal exposure during delivery 54.10 43.84 15 4687 3550 110581047
Muscle contracture 52.84 43.84 14 4688 2794 110581803
Hepatitis fulminant 48.74 43.84 17 4685 8543 110576054
Hyperthermia malignant 48.29 43.84 14 4688 3886 110580711
Premature delivery 44.39 43.84 23 4679 30609 110553988

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC N01AF03 NERVOUS SYSTEM
ANESTHETICS
ANESTHETICS, GENERAL
Barbiturates, plain
ATC N05CA19 NERVOUS SYSTEM
PSYCHOLEPTICS
HYPNOTICS AND SEDATIVES
Barbiturates, plain
MeSH PA D000777 Anesthetics
MeSH PA D000927 Anticonvulsants
MeSH PA D002492 Central Nervous System Depressants
MeSH PA D006993 Hypnotics and Sedatives
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D018682 GABA Agents
MeSH PA D018686 Anesthetics, Intravenous
MeSH PA D018757 GABA Modulators
CHEBI has role CHEBI:38877 intravenous anaesthetic
CHEBI has role CHEBI:35623 anticonvulsant
CHEBI has role CHEBI:35703 xenobiotic
CHEBI has role CHEBI:35717 sedative
CHEBI has role CHEBI:63726 neuroprotective agent
CHEBI has role CHEBI:66981 ophthalmology drug
CHEBI has role CHEBI:78298 environmental contaminant
CHEBI has role CHEBI:88188 drug allergen

Related Drugs by ATC class:

N01AF Barbiturates, plain 2 drugs
hexobarbitalmethohexital
N05CA Barbiturates, plain 17 drugs
allobarbitalamobarbitalaprobarbitalbarbitalbutobarbitalcyclobarbitaletallobarbitalheptabarbhexobarbitalmethohexitalpentobarbitalproxibarbal show all 17 →

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
General anesthesia indication 50697003
Benign intracranial hypertension indication 68267002 DOID:11459
Epilepsy indication 84757009 DOID:1826
Narcoanalysis indication 302683009
Cerebral ischemia off-label use 287731003
Hypoxia of brain off-label use 389088001
Chronic disease of respiratory system contraindication 17097001
Shock contraindication 27942005
Myxedema contraindication 43153006 DOID:11634
Uremia contraindication 44730006 DOID:4676
Low blood pressure contraindication 45007003
Variegate porphyria contraindication 58275005 DOID:4346
Kidney disease contraindication 90708001 DOID:557
Myasthenia gravis contraindication 91637004 DOID:437
Acute disease of cardiovascular system contraindication 128487001
Asthma contraindication 195967001 DOID:2841
Acute intermittent porphyria contraindication 234422006 DOID:3890
Disease of liver contraindication 235856003 DOID:409
Anemia contraindication 271737000 DOID:2355
Primary adrenocortical insufficiency contraindication 373662000




🐶 Veterinary Drug Use

SpeciesUseRelation
Cats Anesthesia in short to moderately long surgical procedures Indication
Dogs Anesthesia in short to moderately long surgical procedures Indication

🐶 Veterinary products

ProductApplicantIngredients
Combuthal Powder Bimeda Animal Health Limited 2
Sodium Thiopental Zoetis Inc. 1

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 7.46 acidic
pKa2 11.46 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
GABA-A receptor alpha-1/beta-2/gamma-2 Ion channel POSITIVE ALLOSTERIC MODULATOR WOMBAT-PK CHEMBL
GABA-A receptor; anion channel Ion channel IC50 4.53 CHEMBL
Potassium voltage-gated channel subfamily C member 4 Ion channel GATING INHIBITOR IC50 4 IUPHAR

External reference:

IDSource
4018713 VUID
N0000179744 NUI
D00714 KEGG_DRUG
71-73-8 SECONDARY_CAS_RN
4018713 VANDF
4019945 VANDF
C0039925 UMLSCUI
CHEBI:102166 CHEBI
EDP PDB_CHEM_ID
CHEMBL441 ChEMBL_ID
DB00599 DRUGBANK_ID
CHEMBL738 ChEMBL_ID
D013874 MESH_DESCRIPTOR_UI
3000715 PUBCHEM_CID
2579 IUPHAR_LIGAND_ID
JI8Z5M7NA3 UNII
10493 RXNORM
2118 MMSL
2227 MMSL
5570 MMSL
d00388 MMSL
001398 NDDF
004578 NDDF
349829005 SNOMEDCT_US
387448009 SNOMEDCT_US
412605006 SNOMEDCT_US
433 INN_ID

Pharmaceutical products:

None